Selected research
Industry Research
Spirulina Tablet Industry Research Report 2026
Market perspective
The global Spirulina Tablet market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Spirulina Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Spirulina Tablet is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Spirulina Tablet is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Spirulina Tablet include DIC LIFETEC, Yunnan Spirin Biotechnology, Shandong Binzhou Tianjian Biotechnology, Lanbao, Viva Naturals, Triquetra Health, Source Naturals, Solaray (Nutraceutical International Corporation) and Parry Nutraceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Spirulina Tablet market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Spirulina Tablet Market by Company
DIC LIFETEC
Yunnan Spirin Biotechnology
Shandong Binzhou Tianjian Biotechnology
Lanbao
Viva Naturals
Triquetra Health
Source Naturals
Solaray (Nutraceutical International Corporation)
Parry Nutraceuticals
Nutrex Hawaii
Hydrolina Biotech
HealthForce
GreeNatr Premium
Fuqing King Dnarmsa
Cyanotech
Spirulina Tablet Segment by Type
Natural Lakes Aquaculture Spirulina
Plant Breeding Spirulina
Spirulina Tablet Segment by Application
Health Products
Feed
Others
Spirulina Tablet Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spirulina Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Spirulina Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spirulina Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Spirulina Tablet manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Spirulina Tablet by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Spirulina Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Natural Lakes Aquaculture Spirulina
- Plant Breeding Spirulina
Applications
- Health Products
- Feed
- Others
Companies covered
- DIC LIFETEC
- Yunnan Spirin Biotechnology
- Shandong Binzhou Tianjian Biotechnology
- Lanbao
- Viva Naturals
- Triquetra Health
- Source Naturals
- Solaray (Nutraceutical International Corporation)
- Parry Nutraceuticals
- Nutrex Hawaii
- Hydrolina Biotech
- HealthForce
- GreeNatr Premium
- Fuqing King Dnarmsa
- Cyanotech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Spirulina Tablet Market Size (2021-2032)
- 2.2.2 Global Spirulina Tablet Sales (2021-2032)
- 2.2.3 Global Spirulina Tablet Market Average Price (2021-2032)
- 2.3 Spirulina Tablet by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Natural Lakes Aquaculture Spirulina
- 2.3.3 Plant Breeding Spirulina
- 2.4 Spirulina Tablet by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Health Products
- 2.4.3 Feed
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Spirulina Tablet Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Spirulina Tablet Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Spirulina Tablet Revenue of Manufacturers (2021-2026)
- 3.4 Global Spirulina Tablet Average Price by Manufacturers (2021-2026)
- 3.5 Global Spirulina Tablet Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Spirulina Tablet, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Spirulina Tablet, Product Type & Application
- 3.8 Global Manufacturers of Spirulina Tablet, Established Date
- 3.9 Global Spirulina Tablet Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 DIC LIFETEC
- 4.1.1 DIC LIFETEC Company Information
- 4.1.2 DIC LIFETEC Business Overview
- 4.1.3 DIC LIFETEC Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 DIC LIFETEC Spirulina Tablet Product Portfolio
- 4.1.5 DIC LIFETEC Recent Developments
- 4.2 Yunnan Spirin Biotechnology
- 4.2.1 Yunnan Spirin Biotechnology Company Information
- 4.2.2 Yunnan Spirin Biotechnology Business Overview
- 4.2.3 Yunnan Spirin Biotechnology Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Yunnan Spirin Biotechnology Spirulina Tablet Product Portfolio
- 4.2.5 Yunnan Spirin Biotechnology Recent Developments
- 4.3 Shandong Binzhou Tianjian Biotechnology
- 4.3.1 Shandong Binzhou Tianjian Biotechnology Company Information
- 4.3.2 Shandong Binzhou Tianjian Biotechnology Business Overview
- 4.3.3 Shandong Binzhou Tianjian Biotechnology Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shandong Binzhou Tianjian Biotechnology Spirulina Tablet Product Portfolio
- 4.3.5 Shandong Binzhou Tianjian Biotechnology Recent Developments
- 4.4 Lanbao
- 4.4.1 Lanbao Company Information
- 4.4.2 Lanbao Business Overview
- 4.4.3 Lanbao Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lanbao Spirulina Tablet Product Portfolio
- 4.4.5 Lanbao Recent Developments
- 4.5 Viva Naturals
- 4.5.1 Viva Naturals Company Information
- 4.5.2 Viva Naturals Business Overview
- 4.5.3 Viva Naturals Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Viva Naturals Spirulina Tablet Product Portfolio
- 4.5.5 Viva Naturals Recent Developments
- 4.6 Triquetra Health
- 4.6.1 Triquetra Health Company Information
- 4.6.2 Triquetra Health Business Overview
- 4.6.3 Triquetra Health Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Triquetra Health Spirulina Tablet Product Portfolio
- 4.6.5 Triquetra Health Recent Developments
- 4.7 Source Naturals
- 4.7.1 Source Naturals Company Information
- 4.7.2 Source Naturals Business Overview
- 4.7.3 Source Naturals Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Source Naturals Spirulina Tablet Product Portfolio
- 4.7.5 Source Naturals Recent Developments
- 4.8 Solaray (Nutraceutical International Corporation)
- 4.8.1 Solaray (Nutraceutical International Corporation) Company Information
- 4.8.2 Solaray (Nutraceutical International Corporation) Business Overview
- 4.8.3 Solaray (Nutraceutical International Corporation) Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Solaray (Nutraceutical International Corporation) Spirulina Tablet Product Portfolio
- 4.8.5 Solaray (Nutraceutical International Corporation) Recent Developments
- 4.9 Parry Nutraceuticals
- 4.9.1 Parry Nutraceuticals Company Information
- 4.9.2 Parry Nutraceuticals Business Overview
- 4.9.3 Parry Nutraceuticals Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Parry Nutraceuticals Spirulina Tablet Product Portfolio
- 4.9.5 Parry Nutraceuticals Recent Developments
- 4.10 Nutrex Hawaii
- 4.10.1 Nutrex Hawaii Company Information
- 4.10.2 Nutrex Hawaii Business Overview
- 4.10.3 Nutrex Hawaii Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nutrex Hawaii Spirulina Tablet Product Portfolio
- 4.10.5 Nutrex Hawaii Recent Developments
- 4.11 Hydrolina Biotech
- 4.11.1 Hydrolina Biotech Company Information
- 4.11.2 Hydrolina Biotech Business Overview
- 4.11.3 Hydrolina Biotech Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hydrolina Biotech Spirulina Tablet Product Portfolio
- 4.11.5 Hydrolina Biotech Recent Developments
- 4.12 HealthForce
- 4.12.1 HealthForce Company Information
- 4.12.2 HealthForce Business Overview
- 4.12.3 HealthForce Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 HealthForce Spirulina Tablet Product Portfolio
- 4.12.5 HealthForce Recent Developments
- 4.13 GreeNatr Premium
- 4.13.1 GreeNatr Premium Company Information
- 4.13.2 GreeNatr Premium Business Overview
- 4.13.3 GreeNatr Premium Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 GreeNatr Premium Spirulina Tablet Product Portfolio
- 4.13.5 GreeNatr Premium Recent Developments
- 4.14 Fuqing King Dnarmsa
- 4.14.1 Fuqing King Dnarmsa Company Information
- 4.14.2 Fuqing King Dnarmsa Business Overview
- 4.14.3 Fuqing King Dnarmsa Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Fuqing King Dnarmsa Spirulina Tablet Product Portfolio
- 4.14.5 Fuqing King Dnarmsa Recent Developments
- 4.15 Cyanotech
- 4.15.1 Cyanotech Company Information
- 4.15.2 Cyanotech Business Overview
- 4.15.3 Cyanotech Spirulina Tablet Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Cyanotech Spirulina Tablet Product Portfolio
- 4.15.5 Cyanotech Recent Developments
5 Global Spirulina Tablet Market Scenario by Region
- 5.1 Global Spirulina Tablet Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Spirulina Tablet Sales by Region: 2021-2032
- 5.2.1 Global Spirulina Tablet Sales by Region: 2021-2026
- 5.2.2 Global Spirulina Tablet Sales by Region: 2027-2032
- 5.3 Global Spirulina Tablet Revenue by Region: 2021-2032
- 5.3.1 Global Spirulina Tablet Revenue by Region: 2021-2026
- 5.3.2 Global Spirulina Tablet Revenue by Region: 2027-2032
- 5.4 North America Spirulina Tablet Market Facts & Figures by Country
- 5.4.1 North America Spirulina Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Spirulina Tablet Sales by Country (2021-2032)
- 5.4.3 North America Spirulina Tablet Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Spirulina Tablet Market Facts & Figures by Country
- 5.5.1 Europe Spirulina Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Spirulina Tablet Sales by Country (2021-2032)
- 5.5.3 Europe Spirulina Tablet Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Spirulina Tablet Market Facts & Figures by Country
- 5.6.1 Asia Pacific Spirulina Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Spirulina Tablet Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Spirulina Tablet Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Spirulina Tablet Market Facts & Figures by Country
- 5.7.1 South America Spirulina Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Spirulina Tablet Sales by Country (2021-2032)
- 5.7.3 South America Spirulina Tablet Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Spirulina Tablet Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Spirulina Tablet Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Spirulina Tablet Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Spirulina Tablet Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Spirulina Tablet Sales by Type (2021-2032)
- 6.1.1 Global Spirulina Tablet Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Spirulina Tablet Sales Market Share by Type (2021-2032)
- 6.2 Global Spirulina Tablet Revenue by Type (2021-2032)
- 6.2.1 Global Spirulina Tablet Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Spirulina Tablet Revenue Market Share by Type (2021-2032)
- 6.3 Global Spirulina Tablet Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Spirulina Tablet Sales by Application (2021-2032)
- 7.1.1 Global Spirulina Tablet Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Spirulina Tablet Sales Market Share by Application (2021-2032)
- 7.2 Global Spirulina Tablet Revenue by Application (2021-2032)
- 7.2.1 Global Spirulina Tablet Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Spirulina Tablet Revenue Market Share by Application (2021-2032)
- 7.3 Global Spirulina Tablet Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Spirulina Tablet Value Chain Analysis
- 8.1.1 Spirulina Tablet Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Spirulina Tablet Production Mode & Process
- 8.2 Spirulina Tablet Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Spirulina Tablet Distributors
- 8.2.3 Spirulina Tablet Customers
9 Global Spirulina Tablet Analyzing Market Dynamics
- 9.1 Spirulina Tablet Industry Trends
- 9.2 Spirulina Tablet Industry Drivers
- 9.3 Spirulina Tablet Industry Opportunities and Challenges
- 9.4 Spirulina Tablet Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst